Copyright
©The Author(s) 2016.
World J Stem Cells. Aug 26, 2016; 8(8): 231-242
Published online Aug 26, 2016. doi: 10.4252/wjsc.v8.i8.231
Published online Aug 26, 2016. doi: 10.4252/wjsc.v8.i8.231
Figure 1 Algorithmic approach to patients with therapy-related myeloid neoplasms.
1Oken et al[109]; 2Sorror[110]; 3Litzow et al[68]. ECOG: Eastern Cooperative Oncology Group; APL: Acute promyelocytic leukemia; ATRA: All-trans retinoic acid; HiDAC: High-dose cytarabine; HCT-CI: Hematopoietic cell transplant-co-morbidity index.
- Citation: Zahid MF, Parnes A, Savani BN, Litzow MR, Hashmi SK. Therapy-related myeloid neoplasms - what have we learned so far? World J Stem Cells 2016; 8(8): 231-242
- URL: https://www.wjgnet.com/1948-0210/full/v8/i8/231.htm
- DOI: https://dx.doi.org/10.4252/wjsc.v8.i8.231